Company: XERI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003761
Chunk: 45

Company: XERIANT, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 45
---
Stock issued for services  -   -   -   -   2,562,500   26   -   49,974   -   -   50,000                                              Conversion of Series A Preferred to Common Stock  (10,100 )  -   -   -   10,100,000   101   -   (101 )  -   -   -                                              Conversion of convertible notes payable and accrued interest into common stock  -   -   -   -   62,088,888   620   -   577,980   -   -   578,600                                              Net loss  -   -   -   -   -   -   -   -   (527,656 )  (2,612 )  (530,268 )                                             Balance March 31, 2025  672,116  $7   1,000,000  $10   681,131,059  $6,811  $97,900  $22,192,742  $(28,011,467 ) $(2,877,148 ) $(8,591,145 )

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 F-4Table of Contents

XERIANT, INC.  

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT 

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2024 

UNAUDITED 

   Series A Preferred Stock    Series B Preferred Stock    Common Stock   Common Stock To Be  Additional Paid in  Accumulated  Non-Controlling      Shares  Amount  Shares  Amount  Shares  Amount  Issued  Capital   Deficit  Interest   Total  Balance June 30, 2023  757,395  $8   1,000,000  $10   389,433,144  $3,894  $51,950